Results 111 to 120 of about 27,191 (241)

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET).

open access: yes, 2005
Udgivelsesdato: 2005-Oct-15The European Myelofibrosis Network (EUMNET), a European research network on myelofibrosis with myeloid metaplasia (MMM), has developed a definition of response for the disease by using clinicohematologic, histologic, and ...
Briere, Jean   +15 more
core   +1 more source

Myelofibrosis

open access: yesHematology, 2014
Claire, Harrison, Donal, McLornan
openaire   +3 more sources

A Systematic Review of Literature: TNF‐α Blockers and JAK Inhibitors for the Treatment of Stevens‐Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Stevens‐Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections.
Sadaf Salehi   +6 more
wiley   +1 more source

Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
ABSTRACT Background Myeloproliferative neoplasms (MPNs) are clonal hematologic disorders commonly driven by mutations in JAK2, MPL, or CALR. Because routine CALR assays are largely optimized for the canonical Type 1 and Type 2 exon 9 variants, rare noncanonical mutations may be missed, creating diagnostic challenges.
Teresa Maltese   +6 more
wiley   +1 more source

Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY‐1, SIMPLIFY‐2, and MOMENTUM Trials

open access: yeseJHaem
Introduction Myelofibrosis is characterized by debilitating constitutional symptoms and anemia, which negatively impact survival and quality of life.
Ruben A. Mesa   +11 more
doaj   +1 more source

Aktualitások a primer myelofibrosis ellátásában | Actualities in the management of primary myelofibrosis

open access: yes, 2016
Absztrakt A primer myelofibrosis a Philadelphia-negatív krónikus myeloid neoplasiák közé tartozó ritka kórkép, amelyre jellemző a cytopeniák és hepatosplenomegalia kialakulása.
Imelda Marton   +7 more
core   +1 more source

Severe tophaceous gout in the setting of myelofibrosis: A clinical challenge

open access: yesRadiology Case Reports
We illustrate a case of a patient with a history of myelofibrosis, presenting with a clinical picture of presumed infection. Imaging revealed apparent fluid collections and erosions in the ankle/foot, supporting the clinical suspicion of infection ...
Nicole Chin, BA   +5 more
doaj   +1 more source

Primary Myelofibrosis - 3

open access: yes, 2018
An image from a peripheral blood smear showing tears, elliptocytes, and schistocytes seen in a patient with primary myelofibrosis (50X oil immersion).
To, Michelle, Kwon, Gloria
core   +1 more source

282. Megakaryocytes morphology in idiopathic (primary) myelofibrosis

open access: yes, 2003
Idiopathic myelofibrosis (IMF) is a hematopoietic stem cell disorder with hypercellular bone marrow and an increase in abnormal megakaryocytes, varying degrees of marrow fibrosis, and extramedullary hematopoiesis.
Byelinska, I.V.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy